Exosomes have begun to be explored as vehicles for carrying therapeutic payloads, such as short interfering RNA, chemotherapeutics, or CRISPR-Cas9 for genome editing. They have been shown to improve survival in animal models of pancreatic cancer by targeting the oncogenic KRAS gene. This indicates potential for exosomes in cancer therapy, though the mechanisms governing their targeting of specific cells and tissues remain an area of ongoing research.